Tag: biopharma strategy

Larrye Ellis Loss, PharmD, MBA | Board Candidate | Drug Development Consultant | Global Life Sciences Leader

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Lain Anderson: Strategic Leader in Life Sciences and Biopharma Innovation

Lain Anderson is a seasoned leader in healthcare consulting, serving as Managing Director and Co-Head of the Americas Healthcare Sector at L.E.K. Consulting. With nearly two decades of experience advising global biopharma and life sciences companies, he specializes in corporate growth strategy, product commercialization, portfolio prioritization, and investment decision-making. Known for his strategic insight and collaborative approach, Lain helps organizations navigate the intersection of science, market opportunity, and financial performance. His background includes roles at Alnylam Pharmaceuticals and General Electric, along with academic distinction from the Tuck School of Business at Dartmouth and Boston College.